Sterling Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07K Sell
280
-939
-77% -$4.54K ﹤0.01% 3116
2026
Q1
$6.46K Sell
1,219
-321
-21% -$1.98K ﹤0.01% 2612
2025
Q4
$11.9K Buy
1,540
+103
+7% +$918 ﹤0.01% 2520
2025
Q3
$12.7K Buy
1,437
+809
+129% +$6.02K ﹤0.01% 2367
2025
Q2
$2.61K Buy
628
+581
+1,236% +$3.64K ﹤0.01% 2843
2025
Q1
$283 Buy
47
+18
+62% +$110 ﹤0.01% 3046
2024
Q4
$150 Buy
29
+3
+12% +$12 ﹤0.01% 3147
2024
Q3
$78 Buy
+26
New +$71 ﹤0.01% 3211

Other funds holding VSTM

Sterling Capital Management's VSTM Position: Q2 2026 in Review

Sterling Capital Management reduced its Verastem (VSTM) stake by 77% in Q2 2026, selling an estimated $4.54K and leaving 280 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #3116.

Sterling Capital Management first reported a position in VSTM in Q3 2024 and has held it in 8 quarters since. The position peaked at $12.7K in Q3 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Sterling Capital Management held 280 shares of Verastem worth $1.07K as of Q2 2026.
  • Sterling Capital Management sold 939 Verastem shares in Q2 2026, an estimated $4.54K.
  • Verastem made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3116 holding.
  • Sterling Capital Management first reported a position in Verastem in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Verastem position peaked at $12.7K in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.